Elevated IL-6 levels after a stroke may be associated with mortality, adverse short- and long-term outcomes, and functional status, assessed using the modified Rankin Scale (mRS) at 3 months and 1 year [2,45,91,96,103,106,107,114,116,123,124,125,126,137]. This evidence concerns the gene IL6 and Stroke.